Squarepoint’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,650
| Closed | -$219K | – | 3264 |
|
|
2024
Q4 | $219K | Sell |
38,650
-32,074
| -45% | -$182K | ﹤0.01% | 2345 |
|
|
2024
Q3 | $414K | Buy |
+70,724
| New | +$414K | ﹤0.01% | 1858 |
|
|
2023
Q4 | – | Sell |
-31,181
| Closed | -$242K | – | 3019 |
|
|
2023
Q3 | $242K | Buy |
31,181
+20,506
| +192% | +$159K | ﹤0.01% | 2029 |
|
|
2023
Q2 | $122K | Sell |
10,675
-32,526
| -75% | -$372K | ﹤0.01% | 2176 |
|
|
2023
Q1 | $333K | Buy |
+43,201
| New | +$333K | ﹤0.01% | 1632 |
|
|
2022
Q2 | – | Sell |
-20,066
| Closed | -$153K | – | 2680 |
|
|
2022
Q1 | $153K | Buy |
20,066
+5,248
| +35% | +$40K | ﹤0.01% | 1969 |
|
|
2021
Q4 | $40K | Sell |
14,818
-18,439
| -55% | -$49.8K | ﹤0.01% | 2441 |
|
|
2021
Q3 | $87K | Sell |
33,257
-54,703
| -62% | -$143K | ﹤0.01% | 2035 |
|
|
2021
Q2 | $363K | Buy |
87,960
+73,731
| +518% | +$304K | ﹤0.01% | 1828 |
|
|
2021
Q1 | $67K | Buy |
+14,229
| New | +$67K | ﹤0.01% | 2424 |
|
|
2020
Q1 | – | Sell |
-127,179
| Closed | -$1.77M | – | 2497 |
|
|
2019
Q4 | $1.77M | Sell |
127,179
-19,591
| -13% | -$273K | 0.01% | 958 |
|
|
2019
Q3 | $2.53M | Buy |
+146,770
| New | +$2.53M | 0.02% | 733 |
|
|
2019
Q1 | – | Sell |
-34,983
| Closed | -$329K | – | 2403 |
|
|
2018
Q4 | $329K | Buy |
34,983
+19,883
| +132% | +$187K | ﹤0.01% | 1446 |
|
|
2018
Q3 | $286K | Sell |
15,100
-3,700
| -20% | -$70.1K | ﹤0.01% | 1560 |
|
|
2018
Q2 | $367K | Buy |
+18,800
| New | +$367K | ﹤0.01% | 1302 |
|
|
2018
Q1 | – | Sell |
-13,768
| Closed | -$229K | – | 2177 |
|
|
2017
Q4 | $229K | Buy |
+13,768
| New | +$229K | ﹤0.01% | 1711 |
|